Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
A Phase IIIB, Randomized, Open-Label, Multicenter Study of the Safety and Efficacy of GW433908 (700mg BID) Plus Ritonavir (100mg BID) Versus Lopinavir/Ritonavir (400mg/100mg BID) When Administered in Combination with ...
Greenberg, Richard
(PI)
Internal Medicine
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
7/29/04
→
2/29/12
Funding
GlaxoSmithKline:
$60,029.00
View all
View less